Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05473013 · ClinicalTrials.gov registry record · NA

Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

A NA study of Binge-Eating Disorder and Bulimia Nervosa, sponsored by Drexel University.

Recruiting
Registry status
NA
Development phase
264
Enrollment target
1
Study location

NCT05473013: Recruiting NA study of Binge-Eating Disorder and Bulimia Nervosa, sponsored by Drexel University.

NCT05473013 is a NA study of Binge-Eating Disorder and Bulimia Nervosa that is actively recruiting participants, run by Drexel University. The registered enrollment target is 264 participants, below the 1,136-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05473013, a NA study of Binge-Eating Disorder and Bulimia Nervosa, is actively recruiting participants, sponsored by Drexel University.

RECRUITING
Registry status
NA
Development phase
264 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify the independent and combined effects of two types of self-monitoring and two types of micro-interventions when combined with standard cognitive behavioral treatment for bulimia nervosa (BN) and binge eating disorder (BED). The primary aims of this study are (1) to evaluate the optimal complexity of Self-Monitoring and Micro-Interventions on eating pathology (at post-treatment and at 6 and 12-month follow-ups and (2) to test the hypotheses that the optimal complexity level of each component is moderated by baseline deficits in self-regulation. The secondary aim will be to test target engagement for each level of complexity for each component, i.e., to test whether higher complexity of each technological components is associated with better rates of therapeutic skill use and acquisition and that improvements in skill use and acquisition are associated with improvements in outcomes. A final exploratory aim will be to quantify the component interaction effects, which may be partially additive (because components overlap and/or there is diminishing return), fully additive, or synergistic (in that component complexities may partially depend on each other).

Primary Outcome

Frequency (number of days and number of instances) of binge eating over the past 28 days assessed by the Eating Disorder Examination

Interventions

  • BEHAVIORAL Behavioral Therapy for Eating Disorders
  • BEHAVIORAL Skills Monitoring On
  • BEHAVIORAL Automated Reminder Messages
  • BEHAVIORAL JITAIs

Study Locations (1)

Pennsylvania

  • Drexel University, Stratton Hall - Philadelphia

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2023-01-06
Est. Completion 2026-03
Phase NA
Drexel University

92 total trials

What NCT05473013 shows while recruiting

NCT05473013 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,136-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (77% lower).

The record links to 4 conditions, with Binge-Eating Disorder appearing as the primary indexed condition, and to 4 interventions - of which Behavioral Therapy for Eating Disorders is the first listed.

NCT05473013 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05473013 about?

NCT05473013 is a clinical study titled "Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization". The purpose of this study is to identify the independent and combined effects of two types of self-monitoring and two types of micro-interventions when combined with standard cognitive behavioral treatment for bulimia nervosa (BN) and binge eating disorder (BED). The primary aims of this study are (...

What is the current status of trial NCT05473013?

This trial is currently recruiting. It is a NA study. The enrollment target is 264 participants. The study started on 2023-01-06. Estimated completion is 2026-03.

What conditions does trial NCT05473013 study?

This clinical trial studies the following conditions: Binge-Eating Disorder, Bulimia Nervosa, Binge Eating, Bulimia.

What interventions are being tested in trial NCT05473013?

The interventions under investigation include: Behavioral Therapy for Eating Disorders (BEHAVIORAL), Skills Monitoring On (BEHAVIORAL), Automated Reminder Messages (BEHAVIORAL), JITAIs (BEHAVIORAL).

Who is sponsoring clinical trial NCT05473013?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05473013 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Binge-Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05473013's enrollment target sits among peer trials

264 7th of 37 higher than 31 of 37 other Binge-Eating Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

  • NCT04295863 · 264 participants · Phase 1

    Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

  • NCT05220202 · 264 participants · NA

    MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

  • NCT05858346 · 264 participants · NA

    Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05473013, the US trial registry maintained by the National Library of Medicine. NCT05473013 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.